These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 12591966

  • 21. MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.
    Proca DM, Niemann TH, Porcell AI, DeYoung BR.
    Appl Immunohistochem Mol Morphol; 2000 Jun; 8(2):120-5. PubMed ID: 10937059
    [Abstract] [Full Text] [Related]

  • 22. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS, Shah SS, Torbenson MS, Wu TT.
    Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
    Atta IS.
    Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
    [Abstract] [Full Text] [Related]

  • 24. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M.
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [Abstract] [Full Text] [Related]

  • 25. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers.
    Porcell AI, De Young BR, Proca DM, Frankel WL.
    Mod Pathol; 2000 Jul; 13(7):773-8. PubMed ID: 10912937
    [Abstract] [Full Text] [Related]

  • 26. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L, Vuolo M, Suhrland MJ, Schlesinger K.
    Acta Cytol; 2006 Jul; 50(3):257-62. PubMed ID: 16780018
    [Abstract] [Full Text] [Related]

  • 27. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
    Tsuji M, Kashihara T, Terada N, Mori H.
    Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
    [Abstract] [Full Text] [Related]

  • 28. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY, Wang HL, Hart J, Fleming D, Beard MR.
    Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
    [Abstract] [Full Text] [Related]

  • 29. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B, Boub R, Rahsaz M.
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [Abstract] [Full Text] [Related]

  • 30. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H, Sato Y, Yoneda N, Harada K, Sasaki M, Kitamura S, Sudo Y, Ooi A, Nakanuma Y.
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [Abstract] [Full Text] [Related]

  • 31. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK, Zarbo RJ, Frierson HF, Lee MW.
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [Abstract] [Full Text] [Related]

  • 32. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG, Young RH.
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Diagnostic utility of renal cell carcinoma marker in cytopathology.
    Gokden N, Mukunyadzi P, James JD, Gokden M.
    Appl Immunohistochem Mol Morphol; 2003 Jun; 11(2):116-9. PubMed ID: 12777993
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.